Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| November 23rd, 2026 |
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 20th, 2029 |
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
| October 22nd, 2026 |
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required) |
National Institutes of Health |
| May 25th, 2029 |
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) |
National Institutes of Health |
| June 7th, 2028 |
Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required) |
National Institutes of Health |
| February 17th, 2028 |
Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 1st, 2029 |
NIAMS P30 Centers Program (P30 - Clinical Trial Not Allowed) |
National Institutes of Health |
| July 31st, 2025 |
U.S. Embassy Kuwait PAS Annual Program Statement |
U.S. Mission to Kuwait |
| December 2nd, 2026 |
Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) |
National Institutes of Health |
| October 15th, 2026 |
Maximizing the Scientific Value of Data Generated by the Environmental influences on Child Health Outcomes (ECHO) Program: Dissertation Grant (R36 - Clinical Trial Not Allowed) |
National Institutes of Health |
| July 7th, 2028 |
Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed) |
National Institutes of Health |
| January 27th, 2027 |
Diabetes Research Centers (P30 Clinical Trial Optional) |
National Institutes of Health |
| November 20th, 2025 |
Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
| November 7th, 2025 |
Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 17th, 2025 |
Single Source: National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 30th, 2026 |
The Experimental Therapeutics Clinical Trials Network (ETCTN) Lead Academic Organizations (UM1 Clinical Trial Required) |
National Institutes of Health |
| September 18th, 2026 |
NCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed) |
National Institutes of Health |
| November 24th, 2025 |
Pilot Projects to Enhance the Human Virome Program (R03, Clinical Trials Not Allowed) |
National Institutes of Health |
| January 10th, 2028 |
Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
| July 10th, 2026 |
Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
|
| January 28th, 2026 |
Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research Community in Advancing Medication Repurposing and Repositioning Efforts for Substance Use Disorders (SUDs) (U54 - Clinical Trials Not Allowed) |
National Institutes of Health |
| October 19th, 2026 |
Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All (U01, Clinical Trial Not Allowed) |
National Institutes of Health |
| July 5th, 2029 |
Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 28th, 2025 |
Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 8th, 2027 |
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 7th, 2025 |
Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Disease (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 20th, 2025 |
FY 2025 Competitive Grant Solicitation Anti-Doping Activities |
Office of National Drug Control Policy |
| March 10th, 2026 |
Single Source for Continuation of the Accelerating Medicines Partnership (AMP) in Common Metabolic Diseases (CMD) Knowledge Portal (U01 Research Project (Cooperative Agreement) Clinical Trial not allowed) |
National Institutes of Health |
| March 5th, 2029 |
Research Grants in Clinical Informatics (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 5th, 2029 |
Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| October 21st, 2025 |
Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional) |
National Institutes of Health |
| October 21st, 2025 |
Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 7th, 2025 |
Tuberculosis Research Units (P01 Clinical Trial Optional) |
National Institutes of Health |
| September 25th, 2028 |
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) |
National Institutes of Health |
| June 3rd, 2026 |
Innovation in Behavioral Health (IBH) |
Centers for Medicare & Medicaid Services |
| March 1st, 2028 |
Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 18th, 2026 |
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 18th, 2026 |
NCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required) |
National Institutes of Health |
| October 1st, 2026 |
HEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| November 2nd, 2028 |
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required) |
National Institutes of Health |
